|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Mechanisms involved in the therapeutic properties of mesenchymal stem cells显示文摘 | Meirelles Lda S Fontes AM Covas DT | 2009 | Cytokine Growth Factor Rev2009，20，56： | 1 |
| 2 | Multipotent mesen- chymal stromal ceils obtained from diverse human ts share func- tional properties and gene-expression profile with CD146 + perivascular cells and fibroblasts 显示文摘 | Covas DT Panepucci RA Fontes AM | 2008 | Exp Hematol2008，36，5： | 1 |
| 3 | Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146 perivascular cells and fibroblasts显示文摘 | Covas DT Panepucci RA Fontes AM | 2008 | Exp Hematol2008，36，5： | 1 |
| 4 | Mechanisms involved in the therapeutic properties of mesenchymal stem cells显示文摘 | Meirelles Lda S Fontes AM Covas DT | 2009 | Cytokine Growth Factor Rev2009，20，56： | 1 |
| 5 | Mechanisms involved in the therapeutic properties of mesenchymal stem cel s显示文摘 | Meirel es Lda S Fontes AM Covas DT | | 0，，5： | 1 |
| 6 | Mechanisms involved in the therapeutic properties of mesenchymal stem cells显示文摘 | Meirelles Lda S Fontes AM Covas DT | | 0，，： | 1 |
| 7 | Human hepatic stellate cell line (LX-2) exhibits characteristics of bone marrow-derived mesenchymal stem cells显示文摘 | Castilho-Fernandes A DE Almeida DC Fontes AM | 2011 | Exp Mol Pathol2011，91，3： | 1 |
| 8 | Mechanisms in- volved in the therapeutic properties of mesenchymal stem cells 显示文摘 | Meirelles-Lda S Fontes AM Covas DT | 2009 | Cytokine Growth Factor Rev2009，20，56： | 1 |
| 9 | An enhancer/promoter combination strengthens the expression of blood-coagulation factor VIII in non-viral expression vectors显示文摘 | Pican? o-Castro V Russo-Carbolante EM Fontes AM | 2008 | Genet Mol Res2008，7，2： | 1 |
| 10 | Effect of low-dose gaseous ozone on pathogenic bacteria显示文摘 | Fontes B1 Cattani Heimbecker AM de Souza Brito G | 2012 | BMC Infect Dis2012，18，12： | 1 |
| 11 | Mechanisms involved in the therapeutic properties of mesenchymal sem cells显示文摘 | Meirel es Lda S Fontes AM Covas DT | | 0，，5： | 1 |
| 12 | Microsatellite lo ci:determining the genetic variability of Plasmodium vivax显示文摘 | Rezende AM Tarazona Santos E Fontes CJ | 2010 | TropMed Int Health2010，15，6： | 1 |
| 13 | The chimeric cytokine Hyper-IL-6 enhnces the efficiency of lentiviral gene transfer in hepatocytes both in vitro and in vivo 显示文摘 | Picanco-Castro V Fontes AM Heinz S | 2008 | Biotechnol Lett2008，30，2： | 1 |
| 14 | Mechanisms involved in the therapeutic properties of mesenchymal stem cells 显示文摘 | Meirelles Lda S Fontes AM Covas DT | 2009 | Cytokine Growth Factor Rev2009，20，56： | 1 |
| 15 | Mechanisms involved in the therapeutic properties of mesenchymal stem cells 显示文摘 | Meirelles LS Fontes AM Covas DT | 2009 | Cytokine Growth Factor Rev2009，20，56： | 1 |
| 16 | Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America显示文摘BACKGROUND There has been an increase in cases of inflammatory bowel disease(IBD)in recent years.There is also greater access and availability of immunosuppressive and biological agents,which increase the risk of opportunistic infection despite improving the quality of life and promoting mucosal healing.Tuberculosis(TB)remains a public health problem,and it has a high incidence in several countries.Therefore,knowledge of the risk of developing TB in patients with IBD is important.AIM To evaluate the risk of active TB in patients with IBD under treatment from an endemic area in Latin America.METHODS A standard questionnaire included demographic variables,clinical aspects of IBD disease,history of active TB during treatment,active TB characteristics and evolution,initial screening and results and time from the start of anti-tumor necrosis factor alpha(TNFα)to TB development.RESULTS Azathioprine,anti-TNFα and the combination of these two drugs were associated with a higher risk of active TB incidence.The TNFα blockers increased the relative risk of developing active TB compared to other treatments.All four multivariable models showed that the use of TNFα blockers alone or in combination with azathioprine was an important risk factor for the incidence of active TB.After adjustment for sex,age,type of IBD and latent TB,anti-TNFα with azathioprine increased the relative risk to 17.8 times more than conventional treatment.Late TB,which was diagnosed 3 mo after the start of anti-TNFα,was the most frequent.CONCLUSION Treatment with anti-TNFα increased the risk of active TB in IBD patients from an endemic area in Latin America.This risk was increased when anti-TNFα was combined with azathioprine.The time from the beginning of the treatment to the active TB diagnosis suggests a new TB infection. | Flora Maria Lorenzo Fortes Ney Boa Sorte Victor D Mariano Laila D Andrade Fernanda A Oliveira Monique CA Santos Claudia Ivanilda N dos Santos Catharina A Passos Mila P Pacheco Valdiana C Surlo Neogelia P de Almeida Jaciane AM Fontes Andrea M Pimentel Raquel Rocha Genoile Oliveira Santana | 2020 | World Journal of Gastroenterology2020，26，44： | 1 |
| 17 | Mechanisms in- volved in the therapeutic properties of mesenchymal stem cells 显示文摘 | da Silva Meirelles L Fontes AM Covas DT | 2009 | Cytokine Frowth Factor Rev2009，5，： | 1 |
| 18 | Mechanisms involved in the therapeutic properties of mesenchymal stem cells显示文摘 | Meirelles Lda S Fontes AM Covas DT | | 0，，： | 1 |
| 19 | Mechanisms involved in the therapeutic properties of mesenchymal stem cells显示文摘 | Meirelles Lda S Fontes AM Covas DT | 2009 | Cytokine Growth Factor Rev2009，20，56： | 1 |
| 20 | The chimeric cyto- kine Hyper-IL-6 enhances the efficiency of lentiviral gene transfer in hepatocytes both in vitro and in vivo显示文摘 | Picanco-Castm V Fontes AM Heinz S | 2008 | Biotechnol Lett2008，30，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员